Characterization of Von Willebrand Factor Multimer Structure in Patients With Severe Aortic Stenosis

Autor: Joerg Kellermair, Helmut W. Ott, Christian Reiter, Clemens Steinwender, Juergen Kammler, Josef Tomasits, Hermann Blessberger, Michael Spannagl

Publikováno v: Clinical and Applied Thrombosis/Hemostasis

Acquired von Willebrand syndrome (AVWS) associated with severe aortic stenosis (AS) has been frequently subclassified into a subtype 2A based on the deficiency of high-molecular-weight (HMW) multimers as it is seen in inherited von Willebrand disease

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::823eb1d651b855019f835533adfc088e
https://doi.org/10.1177/1076029617744321

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Native multimer analysis of plasma and platelet von Willebrand factor compared to denaturing separation: Implication for the interpretation of satellite bands

Autor: Hohenstein, Kurt

Externí odkaz: http://hdl.handle.net/11858/00-1735-0000-000D-F038-D

Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)

Autor: U. Budde, Claudine Mazurier, Javier Batlle, Lars Holmberg, Giancarlo Castaman, A Perez, Jeroen Eikenboom, Jenny Goudemand, Zdena Vorlova, E. Drewke, K. Will, Reinhard Schneppenheim, Francesco Rodeghiero, Stefan Lethagen, Anne Goodeve, David Habart, Frank Hill, John Pasi, Ian R. Peake, Augusto B. Federici, Dominique Meyer, Jørgen Ingerslev

Publikováno v: Budde, U, Schneppenheim, R, Eikenboom, J, Goodeve, A, Will, K, Drewke, E, Castaman, G, Rodeghiero, F, Federici, A B, Batlle, J, Pérez, A, Meyer, D, Mazurier, C, Goudemand, J, Ingerslev, J, Habart, D, Vorlova, Z, Holmberg, L, Lethagen, S, Pasi, J, Hill, F & Peake, I 2008, ' Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD) ', Journal of Thrombosis and Haemostasis, vol. 6, no. 5, pp. 762-71 . https://doi.org/10.1111/j.1538-7836.2008.02945.x

Udgivelsesdato: 2008-May BACKGROUND: Type 1 von Willebrand disease (VWD) is a congenital bleeding disorder characterized by a partial quantitative deficiency of plasma von Willebrand factor (VWF) in the absence of structural and/or functional VWF def

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18c0143d4570adc6785b7038d9e83094
http://hdl.handle.net/2434/46213

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.